(SXRW) iShares VII - iShares FTSE - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00B53HP851 • UK Large-Cap Equity
SXRW: Equity, Stocks, ETF, Index, Fund
The iShares VII PLC - iShares FTSE 100 ETF GBP Acc (XETRA:SXRW) is a well-structured financial instrument designed to provide investors with exposure to the UK equity market. As part of the iShares family, it leverages BlackRocks extensive resources and expertise in indexing. The fund is domiciled in Ireland, which often appeals to investors seeking tax-efficient investment vehicles in Europe. It tracks the Morningstar UK All Cap TME NR GBP index, offering a diversified portfolio that includes a broad range of UK companies across various market capitalizations.
From a structural perspective, the ETF is listed on XETRA, making it accessible to German and European investors. It is classified under the UK Large-Cap Equity category, which suggests a focus on larger, more established companies within the UK market. This categorization aligns with the funds underlying index, which likely includes a mix of blue-chip firms and other prominent UK-listed entities. The ticker symbol SXRW is specific to its listing on XETRA, and the fund is denominated in euros, which is important for currency considerations in investment decisions.
In terms of portfolio composition, the funds assets under management (AUM) stand at approximately 2.16 billion euros, indicating a sizable and liquid investment vehicle. While specific valuation metrics like P/E, P/B, and P/S are not directly applicable to the fund itself, these figures are typically derived from the underlying index constituents. The absence of these metrics in the provided data may reflect the funds focus on tracking the index rather than actively managing valuations. The expense ratio, while not explicitly mentioned, is generally in line with other iShares ETFs, which are known for their cost-efficiency.
For investors and fund managers, this ETF offers a straightforward way to gain exposure to the UK market without the need for individual stock selection. Its tracking error relative to the Morningstar index is typically minimal, ensuring that investors receive returns closely aligned with the underlying index. Additionally, the funds dividend distribution policy and yield are important considerations for income-focused investors. Liquidity is another key factor, as the funds size and listing on XETRA ensure that it can be easily bought and sold without significant market impact.
Its also worth noting that the funds broad market exposure reduces single-stock risk, making it a more conservative investment choice compared to individual equities. However, it still carries market risk tied to the performance of UK companies. Investors should consider their overall portfolio allocation, risk tolerance, and investment objectives before adding this ETF to their holdings. The funds structure and tracking capabilities make it a valuable tool for diversification and long-term growth within a European or global equity portfolio.
Additional Sources for SXRW ETF
SXRW ETF Overview
Market Cap in USD | 2,331m |
Category | UK Large-Cap Equity |
TER | 0.07% |
IPO / Inception | 2010-01-26 |
SXRW ETF Ratings
Growth 5y | 79.7% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -7.12 |
Analysts | - |
Fair Price Momentum | 204.42 EUR |
Fair Price DCF | - |
SXRW Dividends
No Dividends PaidSXRW Growth Ratios
Growth Correlation 3m | 82.6% |
Growth Correlation 12m | 91% |
Growth Correlation 5y | 96.8% |
CAGR 5y | 12.21% |
CAGR/Max DD 5y | 0.56 |
Sharpe Ratio 12m | 1.90 |
Alpha | 9.44 |
Beta | 0.49 |
Volatility | 17.25% |
Current Volume | 2.1k |
Average Volume 20d | 2.5k |
As of March 09, 2025, the stock is trading at EUR 202.30 with a total of 2,099 shares traded.
Over the past week, the price has changed by -2.76%, over one month by -0.37%, over three months by +3.35% and over the past year by +18.99%.
Yes. Based on ValueRay Analyses, iShares VII - iShares FTSE (XETRA:SXRW) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 79.72 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SXRW as of March 2025 is 204.42. This means that SXRW is currently overvalued and has a potential downside of 1.05%.
iShares VII - iShares FTSE has no consensus analysts rating.
According to ValueRays Forecast Model, SXRW iShares VII - iShares FTSE will be worth about 228.7 in March 2026. The stock is currently trading at 202.30. This means that the stock has a potential upside of +13.03%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 228.7 | 13% |